mifepristone has been researched along with Adrenal Cancer in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arumugam, D; Belokovskaya, R; Geer, EB; Goddard, GM; Izadmehr, S; Levine, AC; Ravikumar, A | 1 |
Chadarevian, R; Debono, M; Eastell, R; Newell-Price, J; Ross, RJ | 1 |
Albertini, A; Di Lorenzo, D; Fenaroli, A; Ferrari, F; Rigaud, G; Savoldi, G | 1 |
Foeken, K; Lamberts, SW; van der Lely, AJ; van der Mast, RC | 1 |
1 trial(s) available for mifepristone and Adrenal Cancer
Article | Year |
---|---|
Mifepristone reduces insulin resistance in patient volunteers with adrenal incidentalomas that secrete low levels of cortisol: a pilot study.
Topics: Adrenal Gland Neoplasms; Aged; Biomarkers, Tumor; Female; Humans; Hydrocortisone; Hypothalamus; Insulin Resistance; Male; Middle Aged; Mifepristone; Pilot Projects; Pituitary-Adrenal System; Safety | 2013 |
3 other study(ies) available for mifepristone and Adrenal Cancer
Article | Year |
---|---|
MIFEPRISTONE TREATMENT FOR MILD AUTONOMOUS CORTISOL SECRETION DUE TO ADRENAL ADENOMAS: A PILOT STUDY.
Topics: Adenoma; Adrenal Gland Neoplasms; Humans; Hydrocortisone; Mifepristone; Pilot Projects; Quality of Life | 2019 |
The glucocorticoid receptor regulates the binding of C/EPBbeta on the alpha-1-acid glycoprotein promoter in vivo.
Topics: Adrenal Gland Neoplasms; Animals; Base Sequence; Binding Sites; Carcinoma, Hepatocellular; CCAAT-Enhancer-Binding Proteins; Chromatin; Deoxyribonuclease I; Dexamethasone; DNA Footprinting; DNA-Binding Proteins; Hormone Antagonists; Mifepristone; Molecular Sequence Data; Mutation; Nuclear Proteins; Orosomucoid; Polymerase Chain Reaction; Promoter Regions, Genetic; Rats; Receptors, Glucocorticoid; Transcription, Genetic; Tumor Cells, Cultured | 1997 |
Rapid reversal of acute psychosis in the Cushing syndrome with the cortisol-receptor antagonist mifepristone (RU 486).
Topics: Acute Disease; Adrenal Gland Neoplasms; Adult; Cushing Syndrome; Female; Glucocorticoids; Humans; Male; Mifepristone; Psychotic Disorders | 1991 |